Delivery Order SPE2DB20D2002-SPE2DB22FL36D
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $6,176.99. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat type 2 diabetes. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 IDC with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $1,381.12. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. This order is part of a larger $999,999,999 IDC held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a variety of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,011.79, is a delivery order issued under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a prescription medication used to manage diabetes. The contract, valued at $1,963.28, is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,081.92 firm fixed-price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,153.55. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, which are used to treat diabetes. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is responsible for providing medical supplies to the U.S. military and other federal agencies. The contract has an ultimate completion date of October 24, 2023 and is a firm...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a prescription medication used to treat diabetes. The $15,125.88 firm fixed-price delivery order was placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $67,510.01 delivery order for the pharmaceutical product Trulicity. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that procures medical supplies and equipment for the U.S. military and veterans' healthcare programs. The contract has an ultimate completion date of March 20, 2023 and is a firm fixed-price delivery order, with no set-aside...
- This federal contract award is a delivery order valued at $5,639.12 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL36DDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The specific delivery order, valued at $2,350.59, is for the procurement of Trulicity 0.75 mg/0.5 ml pen 0.5ml, a medication used to manage diabetes. This contract award was made through full and open competition, with no set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying essential medical products to federal government agencies, including the DLA and the Department of Justice.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 4/29/22 |